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compared to those without both factors (HR: 3.222; p< 0.001). Patients
with either one of the two risk factors experienced about a two-fold
increased risk as compared to those without both factors (with DM, HR:
2.184, p ¼ 0.024; with ureteral involvement, HR: 2.006, p ¼ 0.003).
Conclusion: Ureteral involvement and DM are signiﬁcantly related to
bladder recurrence after RNU in patients with UUT-UC.
PD8-2:
HYDRONEPHROSIS INDEPENDENTLY PREDICTS WORSE OUTCOME OF
UPPER TRACT UROTHELIAL CARCINOMA IN PATIENTS PRESENTING
WITH SIMULTANEOUS FLANK PAIN
Hsin-Chih Yeh 1,2, Ching-Chia Li 1,2, Chun-Nung Huang 2, Hung-Lung
Ke 2, Wei-Ming Li 2, Wen-Jeng Wu 2. 1Department of Urology, Kaohsiung
Municipal Ta-Tung Hospital, Kaohsiung, Taiwan; 2Department of Urology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Purpose: We aimed to investigate the impact of preoperative hydro-
nephrosis (HN) and ﬂank pain on prognosis of patients with upper tract
urothelial carcinoma (UTUC).
Materials and Methods: In total, 472 patients with UTUC managed by
radical nephroureterectomy were included from Kaohsiung Medical Uni-
versity Hospital Healthcare System. Clinicopathological data were
collected retrospectively for analysis. The signiﬁcance of HN, especially
when combined with ﬂank pain, and other relevant factors on cancer-
speciﬁc survival (CSS) and overall survival (OS) were evaluated.
Results: Of the 472 patients, 292 (62%) had preoperative HN and 121
(26%) presented with ﬂank pain. Preoperative HN was signiﬁcantly
associated with age, ﬂank pain, tumor location, and pathological tumor
stage. Preoperative HN and ﬂank pain were signiﬁcant predictors of
non-organ-conﬁned (NOC) UTUC (p ¼ 0.020 and 0.013, respectively).
Kaplan-Meier analysis showed signiﬁcantly poorer OS and CSS in pa-
tients with preoperative HN (p ¼ 0.005 and p ¼ 0.026, respectively) and
in patients with ﬂank pain (p < 0.001 and p ¼ 0.001, respectively) than
those without. However, only simultaneous HN and ﬂank pain inde-
pendently predicted adverse outcome (HR ¼ 2.47, p < 0.001 for OS and
HR ¼ 2.28, p ¼ 0.002 for CSS, respectively) in multivariate Cox pro-
portional hazards models. Notably, there was no difference in survival
between patients with HN but devoid of ﬂank pain and those without
HN.
Conclusion: Both preoperative HN and ﬂank pain predicted NOC UTUC.
When accompanied with ﬂank pain, HN represented an independent
predictor for worse outcome in patients with UTUC.
PD8-3:
INFERIOR SURVIVAL, HIGHER TUMOR RECURRENCE AND PROGRESSION
RATES IN PRIMARY NON-MUSCLE-INVASIVE BLADDERCANCER WITH
IMPAIRED EGFR
Chia-En Li 2, Hui-Ying Liu 1, Chih-Hsiung Kang 1, Ye-In Chang 2, Hsiu-Pei
Tang 2. 1Department of Urology, Chang Kung Memorial Hospital,
Kaohsiung, Taiwan; 2Department of Computer Science and Engineering,
National Sun Yat-sen University, Kaohsiung, Taiwan
Purpose: To evaluate the inﬂuence of preoperative patient-associated
parameters and comorbidities, with special focus on preoperative renal
function on non-muscle-invasive bladder cancer (NMIBC) recurrence,
progression, upper urinary tract (UUT) recurrence, cancer speciﬁc survival
and overall survival.
Materials and Methods: Medical records of 158 patients with ﬁrst diag-
nosis of NMIBC from 2008 to 2010 treated at our department were
reviewed for tumor stage and grade, comorbidities, and putative risk
factors including squamous differentiation, tumor size and count, white
blood cell (WBC), neutrophil to lymphocyte ratio (NL ratio), estimated
glomerular ﬁltration rate (eGFR) by chronic kidney disease-epidemiology
collaboration formula, patient age and gender.
Results: Tumor recurrence was observed in 51 patients (32%) and UUT
recurrence was 5 patients (3%); progression to higher pT was found in 9
patients (6%). Univariate analysis revealed count, grade, size, stage, eGFR
and squamous differentiation as signiﬁcation prediction determinantsfor bladder recurrence. Count, grade, stage, eGFR were signiﬁcation
prediction determinants for progression. Age, grade, stage and eGFR
were signiﬁcation prediction determinants for overall survival. Based on
the results of multivariate analysis, a risk factor model was created to
classify patients with high and low risk of recurrence, progression and
survival.
Conclusion: eGFR, grade and stage are signiﬁcant predictive variables of
NMIBC recurrence, progression and survival. Integrating eGFR into NMIBC
risk calculation helped to discriminate individuals with high and low risk
of cancer recurrence, progression and survival. Conﬁrmatory studies and
external validation are needed to corroborate these ﬁndings.
PD8-4:
THE PREDICTIVE FACTORS FOR CONCURRENT RENAL PELVIS TUMOR OF
PATIENTS WITH URETER CARCINOMA: KAOHSIUNG CHANG GUNG
MEMORIAL HOSPITAL EXPERIENCE
Cheng-Jen Yu, Po-Hui Chiang, Hao-Lun Luo. Department of Urology,
Kaohsiung Chang Gung Memorial Hospital and Chang Gung University
College of Medicine, Kaohsiung, Taiwan
Purpose: The incidence of upper tract urothelial carcinoma (UTUC) and
chronic kidney disease (CKD) are high in southern Taiwan. The renal
sparing surgery (RSS) is an optional choice of treatment of UTUC. This
study was designed to assess the predictive factors on multifocal UTUC.
Materials and Methods: This study was retrospectively designed to
determine the predictive factors on concurrent renal pelvis urothelial
carcinoma (RPUC). From 2004 to 2012, 263 patients with preoperative
solitary ureter tumor underwent radical nephroureterectomy (RNU) at our
tertiary medical center. Perioperative data were recorded by chart review.
Multivariate binary logistic regression was used to analyze the impact of
risk factors for concurrent RPUC by SPSS ver. 17.
Results: There are thirty-eight patients (14%) had postoperative ﬁnding of
concurrent RPUC. There is no signiﬁcant difference of grade of preopera-
tive hydronephrosis between both groups (p ¼ 0.533), and there are sig-
niﬁcant difference of proportion of preoperative CKD stage (p¼ 0.005) and
past history of bladder cancer (p ¼ 0.003) between both groups. Multi-
variate analysis disclosed both bladder cancer history (odds ratio: 2.948;
p ¼ 0.005) and preoperative CKD stage >3 (odds ratio: 2.207; p ¼ 0.033)
are independent risk factors for multifocal UTUC.
Conclusion: In addition to the EAU guideline of conservative treatment for
UTUC, we supposed that past history of bladder cancer and preoperative
CKD stage greater than stage 3 are both important and independent risk
factors to synchronously multifocal UTUC. More consequent studies about
the oncologic outcome of RSS are necessary.
PD8-5:
IS THE CALCIFIED LESION OF BLADDER WALL AFTER INTRAVESICAL
MITOMYCIN-C THERAPY FOR SUPERFICIAL BLADDER CANCER SHOULD
BE RESECTED?
Jing-Dung Shen 1,2, Jane-Dar Lee 1, Tai-Lung Cha 2, Guang-Haun Sun 2, Dah-
Shyong Yu 2, Sun-Yran Chang 2, En Meng 2. 1Divisions of Urology,
Department of Surgery, Taichung Armed Forces General Hospital, Taichung,
Taiwan; 2Division of Urology, Departments of Surgery, Tri-Service General
Hospital, National Defense Medical Center, Taipei, Taiwan
Purpose: Intravesical therapy with Mitomycin-C and Bacillus Calmette-
Guerin is a standard treatment for superﬁcial bladder cancer. Owing to the
worldwide shortage of Bacillus Calmette-Guerin, the use of Mitomycin-C
for intravesical therapy is increasing. Sometimes, calciﬁed lesion of bladder
wall at previous resection site were found during scheduled cystoscopy.
Are these lesions should be resected?
Materials and Methods: We retrospectively included 43 non-muscle
invasive bladder cancer patients who were treated with transurethral
resection of bladder tumor followed by adjuvant intravesical mitomycin C
intravesical therapy between 2011 and 2014 at Tri-service General Hos-
pital. These patients were classiﬁed into calciﬁcation and non-calciﬁcation
groups. This study analyzes the characteristic of these two groups in order
to ﬁnd the predictive factor of bladder wall calciﬁcation and the meaning
of bladder wall calciﬁcation in clinical practice.
Abstracts / Urological Science 26 (2015) S1eS25S16Results: Of the 43 patients, 7 had calciﬁed lesion of bladder wall after
intravesical mitomycin-C therapy and the other 36 didn't. The urinary pH
is lower in calciﬁcation group (5.43± 0.071) than non-calciﬁcation group
(5.94± 0.150, p ¼ 0.002). The calciﬁcation group reveal the tendency of
higher tumor recurrent rate than non-calciﬁcation group (28.6% V.S. 2.8%,
p ¼ 0.014).
Conclusion: The patients with lower urinary pH during intravesical
mitomycin-C therapy are prone to have bladder wall calciﬁcation and
higher tumor recurrent rate. Our results revealed the calciﬁed lesion might
be the cover of tumor. Based on these results, we suggest resect the
calciﬁed lesion.
PD8-6:
THE PROGNOSTIC VALUE OF NEUTROPHIL AND LYMPHOCYTE RATIO IN
PATIENT RECEIVING RADICAL CYSTECTOMY OPERATIONS
Ching-wei Huang, Ying-Hsu Chang. Department of Surgery, Division of
Urology, Chang Gung Memorial Hospital at Linkou, Taiwan
Purpose: To identify Neutrophil/Lymphocyte ratio(NLR) as a prognostic
predictor inﬂuencing long term survival for patient undergoing radical
cystectomy with different urothelial carcinoma stages
Materials and Methods: We obtained 163 patients who admitted for
urothelial carcinoma and underwent radical cystectomy during 2005-
2008 in Linkou Chang-Gung Memorial Hospital. The preoperative factors
including gender, tumor pathology, tumor size, pathological characteris-
tics and pre-OP lab data were analysed. The paired t-test was used to
analyze associations between categorical variables. Multivariate analysis
was performed. Signiﬁcance level was set at p<0.05. All stastical analysis
was done with SPSS for MAC.
Results: This study included total 163 cases with mean patient age as 66.6
years old. The most common cell type as inﬁltrating urothelial carcinoma
and 5-year overall survival rate was 43%. We obtained pre-OP lab data for
calculating NLR and set different cut points for comparing signiﬁcance in
different groups. When NLR was set as 3, there was signiﬁcance survival
difference between two groups(NLR>3, Overall Survival¼ 45.92M; NLR<3,
OS ¼ 56.62M). However, when moving on into multivariate analysis, the
NLR was not an independent prognostic factor for patient receiving radical
cystectomies. (HR ¼ 1.06, 95% CI ¼ 0.45-2.50, p ¼ 0.90).
Conclusion: In patient undergoing radical cystectomies, NLR showed
overall survival difference between group when cut point was set at 3.
However, further multivariate analysis failed to showed independent
prognostic power of NLR in current patient cohort.Podium-9
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PD9-1:
THE EFFECT OF EXTRACORPOREAL SHOCKWAVE ON CAVERNOUS NERVE
STIMULATION-INDUCED INTRACAVERNOUS PRESSURE INCREASE IN THE
DIABETIC RAT
Kuang-Kuo Chen, Luke S. Chang. Department of Urology, Taipei Veterans
General Hospital, and Shu-Tien Urological Research Center, National Yang-
Ming University, Taiwan
Purpose: Diabetes mellitus (DM) is commonly associated with erectile
dysfunction (ED). Low-intensity extracorporeal shock wave therapy (LI-
ESWT) has been used to treat patients with ED. However, the pre-clinical
investigation of LI-ESWT for ED is still not enough. Therefore, the objective
of this study was to investigate the effect of LI-ESW on cavernous nerve
(CN) stimulation-induced intracavernous pressure (ICP) increase in the
diabetic rat.
Materials and Methods: Male adult Sprague-Dawley rats (250-300 g)
were used. Intraperitoneal injection of streptozotocin (STZ) 70 mg/kg was
done to induce DM in the rats. Only rats with blood glucose levels of
greater than 300 mg/dl (hyperglycemia) three days after STZ injection
were used. Three groups of experimental animals were designed as
following: 1)ESW (0.05 mJ/mm2) to penile shaft, 800 shocks twice a week
for 2 weeks, 2)ESW (0.05 mJ/mm2) to penile shaft, 1200 shocks twice aweek for 2 weeks, and 3)application of probe without ESW to penile shaft
twice a week for 2 weeks as a sham control. A 26-gauge needle was
inserted into the corpus cavernosum to monitor the ICP. The CN was
electrically stimulatedwith parameters (5 and 7.5 V, 20 Hz, 2 ms,1 minute)
on the 14th day after 2-week ESW in each of the three group rats. The
amount of ICP increase was the difference between the peak ICP and
resting ICP.Wilcoxon signed rank test andMann-Whitney U test were used
for statistical analysis.
Results: There was a signiﬁcant increase of ICP from resting
5.3± 0.8 mmHg, 12.0± 1.9 mmHg and 5.2± 1.3 mmHg to a peak at
74.8± 6.5 mmHg (p ¼ 0.027), 81.0± 6.1 mmHg (p ¼ 0.028) and
45.8± 6.2 mmHg (p¼ 0.028) after CN stimulationwith parameters 7.5 V in
group 1, 2 and 3 rats, respectively. The corresponding amount of ICP in-
crease were 69.5± 6.9 mmHg, 69.0± 5.4 mmHg and 40.7± 5.0 mmHg in
group 1, 2 and 3 rats, respectively. There was a signiﬁcant greater amount
of ICP increase in the group 1 (p ¼ 0.015) and group 2 rats (p ¼ 0.015) as
compared with group 3 rats (sham control), respectively.
Conclusion: The results suggest that low-intensity extracorporeal shock
wave may have a signiﬁcant enhancing effect on cavernous nerve stimu-
lation-induced intracavernous pressure increase in the diabetic rat.
PD9-2:
EFFECT OF TADALAFIL ONCE DAILY ON ERECTILE FUNCTION IN
PATIENTS AFTER ROBOTIC ASSISTED RADICAL PROSTATECTOMY WITH
BILATERAL NERVE SPARING
I-Yen Lee, Yen-Chuan Ou, Min-Che Tung, Chao-Yu Hsu, Jue-Hawn
Yin, Wei-Chun Weng, Li-Hua Huang, Zhon-Min Huang. Divisions of
Urology, Department of Surgery, Tungs' Taichung MetroHarbor Hospital,
Taichung, Taiwan
Purpose: The erectile function post nerve-sparing radical prostatectomy
remains a problem to resolve. We measured the erectile function in pa-
tients who using Tadalaﬁl 5 mg once daily for 6 months after receiving
nerve-sparing radical prostatectomy.
Materials and Methods: A total of 69 patients less than 70 years of age
who had adenocarcinoma of prostate with normal preoperative EF un-
dergoing nerve-sparing Robotic assisted radical prostatectomy were
included in our trial. They used Tadalaﬁl 5mg once daily for 6 months
after surgery. The “Internal Index of Erectile Function-Erectile Function
domain (IIEF-EF)” score was used to measure the erectile function in
patients who took tadalaﬁl 5 mg once daily for 6 months after receiving
bilateral or unilateral nerve-sparing robotic assisted radical prostatec-
tomy. The baseline of IIEF score before and after prostatectomy was
recorded.
Results: After using Tadalaﬁl 5mg once daily for 6 months, 48 patients
(69.6%) had higher or equal IIEF score than preoperative evaluation.
However, 21 patients (30.4%) had lower IIEF score than preoperative score.
Twenty-four (35%) patients had complaint of ﬂank soreness but the
symptom mostly alleviating after 5 weeks usage. One patient could not
tolerate the side effect of insomnia after 2 months of tadalaﬁl usage and
was excluded in this trial.
Conclusion: Phosphodiesterase 5 inhibitor (tadalaﬁl 5 mg) is safe and
tolerable in patients who receive bilateral or unilateral nerve-sparing ro-
botic assisted radical prostatectomy. Tadalaﬁl 5 mg once daily was proven
to be effective in restoring erectile function and was suggested to use in
patients after radical prostatectomy. The effect after cessation of tadalaﬁl
5 mg once daily need to be evaluated in the future.
PD9-3:
THE EFFICACY OF INCREASING COITAL FREQUENCY IN THE TREATMENT
OF PREMATURE EJACULATION
Yu Chen, Shih-Tsung Huang, Hsin-Chien Huang, Yu-Chao Hsu, Po-Chih
Chang, Ming-Li Hsieh. Division of Urology, Department of Surgery, Chang
Gung Memorial Hospital, Taoyuan, Taiwan
Purpose: Premature ejaculation is a common consultation in urological
clinic. This study is designed to compare the early outcome of increasing
coital frequency and traditional behavioral therapy in the treatment of
patients with premature ejaculation.
